![]() RTT News | Sucampo Pharma's Lubiprostone Meets Key Goal In Phase III Trial For OBD - Update RTT News Amitiza is already approved by the FDA for the treatment of chronic idiopathic constipation in adults of both genders and irritable bowel syndrome with constipation in women aged 18 years and older. In the phase III opioid-induced bowel dysfunction ... Lubiprostone Meets Primary Endpoint in Phase 3 Clinical Trial for Opioid ... |
View the full article

Help
Forums






MultiQuote








